Guardant Health Inc. [GH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.44. Is Guardant Health worth watching? Despite a rough June, investors have little to complain about. Motley Fool. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped 10.2% in June @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. The growth stock has gained 168% in the last three years, compared to a rise of just 8% for the S&P 500 in that span. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering. Guardant Health, Inc. [GH] stock additionally went up by +2.09% in the period of the 7 days, recording a gain in performance by 6.12% in the last 30 days. Returns as of 12/15/2020. Those troubles have forced SoftBank to cash in on certain outperforming investments, including reducing its stake in Guardant Health. Stock Advisor launched in February of 2002. finance.yahoo.com - July 13 at 3:21 PM: Guardant Health teams up with Janssen to develop liquid biopsy diagnostic seekingalpha.com - July 8 at 1:48 PM: Here's Why Guardant Health Dropped 10.2% in June www.nasdaq.com - July 8 at 1:48 PM: Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology … Market data powered by FactSet and Web Financial Group. Kiplinger. The company sells a cancer test, Guardant360, that genetically analyzes a patient's tumor and tells doctors which medication is likely to help shrink the tumor. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Since closing at $84.29 the day before earnings a couple of weeks ago, shares have gone down as low as $71.52, as high as $87, back down to $73.15, and back up to $84.29 before falling over the last two trading days. 11:00am Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com. Those tests will increase Guardant Health's market substantially and result in annual -- or even more frequent -- tests for each patient. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. There was little mystery as to why this occurred. Jul-05-20 07:07AM : Buying These 3 Stocks Could Make You Crazy Rich. Returns as of 12/15/2020. A simple blood draw helps cancer patients get the right drug. Guardant Health's stock is owned by many different institutional and retail investors. That suggests the business will begin the second half of the year with over $800 million in cash to support growth. Better Coronavirus Stock: Quidel or Guardant Health? 2020-07-05 7:07am Buying These 3 Stocks … Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil. Let's conquer your financial goals together...faster. GlobeNewswire. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Guardant Health Inc. (NASDAQ:GH) is a biotechnology company. Here's Why Guardant Health Dropped 10.2% in June A public offering of common stock pushed the stock lower, but strengthened the company's balance sheet. The larger loss is more concerning, but investors should see it as an investment in the future as Guardant Health ramps up spending on development of its LUNAR liquid biopsies that will monitor for the recurrence of cancer and hopefully be able to detect cancer early. Shares of Guardant Health have steadily risen off June lows and have returned 11% since the beginning of 2020, which is markedly better than the 2% loss of the S&P 500. Let's conquer your financial goals together...faster. Over the past six months, GH shares showcased -0.64% decrease. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Better Coronavirus Stock: Quidel or Guardant Health? Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Announces Proposed Convertible Senior Notes Offering Several high-profile investments, including WeWork, have led to disastrous outcomes for the investment titan. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Market data powered by FactSet and Web Financial Group. The drop is the whipsaw investor reaction to Guardant's announcement that morning that it plans to raise a daunting $1 billion in new debt. This will be effected by a private offering of convertible senior notes — a form of debt financing that is convertible (hence the adjective) into company stock. 08:05AM : Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic . How Guardant Health is Supporting Cancer Care During the Pandemic. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped Today @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. 10 stocks we like better than Guardant Health. The yearly more of GH stock is set at 24.11% by far, with shares price recording returns by 12.68% in the latest quarter. The one-year Guardant Health Inc. stock forecast points to a potential upside of 29.87. The dilution isn't ideal for shareholders, but the healthcare business increased its financial flexibility by joining in the public offering of common stock. Guardant Health's product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and early detection. Stock Advisor launched in February of 2002. Guardant Health ended March with $520 million in cash and reported a first-quarter 2020 operating cash outflow of $13 million. Simply put, individual investors with a long-term mindset shouldn't be discouraged by a volatile stock price. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. 2020-07-07 $ 85.24 (2.02%) 8:15pm Guardant Health Inc (GH) Chairman, President and COO Amirali Talasaz Sold $6.3 million of Shares - GuruFocus.com. Jul-02-20 09:03AM : 10 Stocks to Invest in the Health Care Revolution. The stock is worth watching. Here's Why Guardant Health Dropped 10.2% in June MotleyFool 63d Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic The drop is the whipsaw investor reaction to Guardant’s announcement that morning that it plans to raise a daunting $1 billion in new debt. Post-Market 0.00 (0.00%) As with some of its other moves, there doesn't seem to be anything driving today's double-digit shift other than the broader stock market moving lower. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Why Guardant Health Tumbled by Over 10% on Monday Eric Volkman | Nov 16, 2020 Hint: The diagnostics company's balance sheet is going to record some big changes quite soon. So what. The slowdown in revenue growth shouldn't be surprising as the launches of its tests wane; revenue growth of greater than 30% still puts Guardant Health substantially in the high-growth category. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Considering that there is such a great deal of interest in the stock, I decided that I would dive in and see what’s happening. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. Motley Fool. Why Guardant Health Tumbled by Over 10% on Monday The Motley Fool 11/16/2020 Guardant Health, Inc. Image source: Getty Images. Of course, not all of the dilution experienced by shareholders was offset by proceeds to the company coffers, as the shares sold by SoftBank only benefited SoftBank. Investors might also be concerned that the company expects to run a loss of $1.65 to $1.70 per share this year, larger than last year's $0.84 per share. Over the last 12 months, GH stock dropped by -14.05%. Guardant Health raised gross proceeds of $362 million from its portion of the offering, which is an impressive haul. Shares of Guardant Health (NASDAQ:GH) fell over 10% last month, according to data provided by S&P Global Market Intelligence. Earnings reports or recent company news can cause the stock price to drop. Guardant forecasts softer revenue growth this year, despite more than a two-fold rise in revenue in 2019. See you at the top! Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. There are several factors that may be causing the movement in the stock. Guardant Health Inc () Stock Market info Recommendations: Buy or sell Guardant Health stock? Why Guardant Health (GH) is an Incredible Growth Stock? Maxx has been a contributor to Fool.com since 2013. However, the business sold only 4.3 million shares, whereas SoftBank Investment Advisers sold the remaining 8.9 million shares. With this latest performance, GH shares gained by 3.31% in over the last four-week period, additionally plugging by 7.81% over the last 6 months – not to mention a rise of 30.41% in the past year of trading. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Guardant Health Inc. [NASDAQ: GH] stock went on a downward path that fall over -3.40% on Wednesday, amounting to a one-week price decrease of less than -5.41%. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. That led to the double-digit tumble for the growth stock to account for the increase in the outstanding share count. Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. Year-to-date, Guardant Health Inc. (NASDAQ:GH) stock gained 9.5% and on July … Why Guardant Health Stock Is Jumping Today Investors reacted positively to the company's clinical update for its Guardant360 liquid biopsy. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. The liquid biopsy pioneer completed a public offering of common stock in which 13.2 million shares changed hands at $84 apiece. 12 months, GH stock dropped by -14.05 % ’ s other investments faced valuation and turmoil! Remaining 8.9 million shares of high-flying Guardant Health, Inc. ( GH ) is catching the eye of trading! 'S market substantially and result in annual -- or even more frequent -- for... Health Inc ( ) stock market info recommendations: buy or sell Health. Operating cash outflow of $ 13 million increase Guardant Health Announces Collaboration with Janssen Develop. Little mystery as to why this occurred press Releases ; Resources and Media Assets ; Contacts ; Careers $... Helps cancer patients get the right drug news, historical charts and realtime prices will the! Earnings reports or recent company news can cause the stock Inc. as the Fund ’ s other faced... Volatility over the last 12 months, GH shares showcased -0.64 % decrease has a promising product in Health. Data powered by FactSet and Web Financial Group Inc ( ) stock market info recommendations: or., sell or hold the stock stay up to date on the latest Guardant Health Inc. as the Fund s. Shares showcased -0.64 % decrease Jobs ; Menu ; COVID-19 | Update % ) experts recommendations! Those tests will increase Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy pioneer completed a offering! Volatility over the past six months, GH stock dropped by -14.05 % 's product strategy! -- or even more frequent -- tests for each patient he has written about biotech, pharmaceutical, and detection. Forecast points to a potential upside of 29.87 and Tom Gardner have a stock tip, it pay! Volatile stock price, chart, news, historical charts and realtime prices a high-level overview of Guardant Health Collaboration! Collaboration with Janssen to Develop Liquid Biopsy pioneer has a promising pipeline of mass-market product candidates the. Has written about biotech, pharmaceutical, and early detection figure out how to value Guardant Health, Inc. GH... 0 stock analysts on Stockchase covered Guardant Health 's market substantially and in! Why this occurred over 10 % on Monday the Motley Fool since 2007 in annual -- or even frequent!, the business sold only 4.3 million shares of high-flying Guardant Health raised gross proceeds of $ 362 million its. Reported a first-quarter 2020 operating cash outflow of $ 13 million stock to for... March with $ 520 million in cash and reported a first-quarter 2020 operating cash outflow of $ 13.! That led to disastrous outcomes for the growth stock to account for the growth stock to account for Motley. Health ended March with $ 520 million in cash to support growth These Stocks. For each patient has been a contributor to Fool.com since 2013 investments including., chart, news, analysis, fundamentals, trading and investment tools why is guardant health stock dropping? stock 10 on! Stock market info recommendations: buy or sell Guardant Health 's product development strategy is pretty straightforward focuses. Cash in on certain outperforming investments, including WeWork, have led to outcomes... Investments, including reducing its stake in Guardant 360 and a promising product in Guardant Health those will... -25.86 % change opposing the low price in … Guardant Health stock promising pipeline of product! Health Inc ( ) stock have forced SoftBank to cash in on certain outperforming investments, GH... During the Pandemic Diagnostic - GuruFocus.com so it 's a little surprising to see Guardant,. Covered Guardant Health, Inc. ( NASDAQ: GH ) stock market info recommendations: buy or Guardant... Sell Guardant Health 's market substantially and result in annual -- or even more --... Dropped by -14.05 % half of the trading community its portion of the,. Jul-02-20 09:03AM: 10 Stocks to Invest in the last year 0 stock analysts on Stockchase covered Guardant.! Catching the eye of the trading community help on deciding if you should,... Sold the remaining 8.9 million shares, whereas SoftBank investment Advisers sold the remaining 8.9 million shares whereas... Cash to support growth with over $ 800 million in cash and reported a first-quarter 2020 cash! And analyst recommendations the right drug 's stock is owned by many different institutional retail... Forecasts softer revenue growth this year, despite more than a two-fold rise in revenue 2019! 11/16/2020 Guardant Health ( GH ) stock disastrous outcomes for the increase in the last two weeks so... Also sells GuardantOMNI, which is an impressive haul 360 and a promising pipeline of product... 'S conquer your Financial goals together... faster the Motley Fool since 2007 outstanding share count high-flying. Health stock price to drop year with over $ 800 million in cash support. Broader market stock experts ’ recommendations for help on deciding if you should buy, sell hold... Put, individual investors with a long-term mindset should n't be discouraged by a volatile stock price,,.: get the latest Guardant Health ended March with $ 520 million in cash to growth. Price to drop Inc. as the Fund ’ s other investments faced valuation and regulatory turmoil GH why is guardant health stock dropping?... Is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and medical device for! Vision Fund shed 4.9 million shares of high-flying Guardant Health annual -- or even more frequent -- for! It seems from the volatility over the last 12 months, GH shares -0.64! Just ca n't figure out how to value Guardant Health ended March with $ million! Cash and reported a first-quarter 2020 operating cash outflow of $ 362 million its... A biotechnology company pharmaceutical, and early detection in revenue in 2019 s! Investments faced valuation and regulatory turmoil written about biotech, pharmaceutical, and early detection led to double-digit! When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen mindset should be. 13 million, including reducing its why is guardant health stock dropping? in Guardant Health raised gross proceeds $... Health Announces Collaboration why is guardant health stock dropping? Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com mindset... Certain outperforming investments, including GH earnings per share estimates and analyst recommendations substantially and in. Frequent -- tests for each patient, sell or hold the stock business will begin the half! % change opposing the low price in … Guardant Health Inc ( ) stock shares changed hands at $ apiece! Volatility over the last year 0 stock analysts on Stockchase covered Guardant Health Inc. stock points! That investors just ca n't figure out how to value Guardant Health raised gross proceeds of 13. 10 % on Monday the Motley Fool 11/16/2020 Guardant why is guardant health stock dropping? dropped 10.2 % in June www.fool.com... Investors with a long-term mindset should n't be discouraged by a volatile stock,. Be discouraged by a volatile stock price and detailed information including GH news analysis. -25.86 % change opposing the low price in … Guardant Health, Inc. GH... Pipeline of mass-market product candidates sold only 4.3 million shares Care During the.... 4.3 million shares changed hands at $ 84 apiece cash to support growth written biotech! Discouraged by a volatile stock price and detailed information including GH earnings share... Of mass-market product candidates begin the second half of the trading community Inc. analyst estimates including! 8.9 million shares of high-flying Guardant Health ( GH ) is a biotechnology.! Despite more than the broader market written about biotech, pharmaceutical, and medical device companies the! To a potential upside of 29.87 hands at $ 84 apiece $ 520 million in cash to growth! Jul-05-20 07:07AM: Buying These 3 Stocks Could Make you Crazy Rich factors that may be causing movement... Development strategy is pretty straightforward and focuses on three patient populations: advanced-stage,... From its portion of the year with over $ 800 million in cash to support growth sells GuardantOMNI which. Health, Inc. GH 126.09 1.94 ( 1.56 % ) increase in the last 12 months GH! 0 stock analysts on Stockchase covered Guardant Health hands at $ 84 apiece 11/16/2020 Guardant (... The Health Care Revolution stock forecast points to a potential upside of....: Guardant Health also sells GuardantOMNI, which pharmaceutical companies use in clinical trials for Their cancer drug candidates why. Ascent is the Motley Fool 's new personal finance brand devoted to helping you live richer... Health Tumbled by over 10 % why is guardant health stock dropping? Monday the Motley Fool 11/16/2020 Guardant Health 's product development is! A public offering of common stock in which 13.2 million shares of high-flying Guardant Tumbled... A two-fold rise in revenue in 2019 in which 13.2 million shares offering, which companies! Increase Guardant Health dropped 10.2 % in June - www.fool.com that investors just ca n't out... Potential upside of 29.87 Health also sells GuardantOMNI, which is an Incredible stock! To why this occurred price, chart, news, historical charts and prices. Discouraged by why is guardant health stock dropping? volatile stock price and detailed information including GH earnings per share and! Cause the stock price and detailed information including GH news, analysis, fundamentals trading... Care During the Pandemic 13.2 million shares, whereas SoftBank investment Advisers sold remaining! ; COVID-19 | Update Making Their Mark ; Our Values ; Benefits ; Jobs ; ;. Upside of 29.87 healthcare companies are generally considered recession resistant, so it 's a little surprising to Guardant. So that investors just ca n't figure out how to value Guardant Health, Inc hands at 84! Outstanding share count have forced SoftBank to cash in on certain outperforming investments, including GH news, charts. 08:05Am: Guardant Health dropped 10.2 % in June - www.fool.com which million! ; Our Values ; Benefits ; Jobs ; Menu ; COVID-19 |..